H.I.G. Capital and Barts Health NHS Trust launch the first applied healthcare innovation building within the Barts Life Sciences Cluster.
Global investment firm H.I.G. Capital has announced a strategic partnership with the Barts Health NHS Trust to deliver the first applied healthcare innovation building within the newly launched Barts Life Sciences Cluster at Cavell Street in London, Whitechapel.
The 170,000 square foot Cavell Street development hopes to pioneer new models of collaboration between clinicians, researchers, and industry and intends to serve as a landmark health innovation project within the Cluster.
Cavell Street will establish a new hub for NHS industry collaboration, enabling companies to work directly with Barts Health clinicians and researchers to shape, test and refine next-generation medtech, AI, digital health and other emerging fields. The development aims to create an environment for applied healthcare innovation where medtech and life sciences organisations can co-develop technologies in real clinical settings in partnership with staff from The Royal London Hospital and other Barts Health hospitals.
“Through the Barts Life Sciences Cluster, we are bringing clinicians, patients, industry, and academia together in new ways,” said Barts Health NHS Trust chief executive Shane DeGaris.
“This first partnership project at Cavell Street begins to turn that ambition into reality. By creating environments where innovation can be shaped directly by NHS teams and tested in real care settings, we aim to improve patient outcomes and support economic opportunity for East London,” he continued.
The Barts Life Sciences Cluster is supported by existing and new facilities of Queen Mary University of London.
